Press Releases + News Year: - Any -2024202320222021202020192018201720162015201420132012201120102009 Items per page 102550 Date Title and Summary View Toggle SummaryMar 15, 2011 PRO-PHARMACEUTICALS REPORTS FULL YEAR and FOURTH QUARTER 2010 FINANCIAL RESULTS View HTML PRO-PHARMACEUTICALS REPORTS FULL YEAR and FOURTH QUARTER 2010 FINANCIAL RESULTS 26.1 KB Toggle SummaryMar 09, 2011 PRO-PHARMACEUTICALS NAMES PETER G. TRABER, M.D., FORMER GLAXOSMITHKLINE CHIEF MEDICAL OFFICER & PRESIDENT EMERITUS OF BAYLOR COLLEGE OF MEDICINE, PRESIDENT & CHIEF EXECUTIVE OFFICER View HTML PRO-PHARMACEUTICALS NAMES PETER G. TRABER, M.D., FORMER GLAXOSMITHKLINE CHIEF MEDICAL OFFICER & PRESIDENT EMERITUS OF BAYLOR COLLEGE OF MEDICINE, PRESIDENT & CHIEF EXECUTIVE OFFICER 19 KB Toggle SummaryFeb 08, 2011 PRO-PHARMACEUTICALS TO PRESENT CORPORATE UPDATE AT BIO CEO & INVESTOR CONFERENCE View HTML PRO-PHARMACEUTICALS TO PRESENT CORPORATE UPDATE AT BIO CEO & INVESTOR CONFERENCE 18 KB Toggle SummaryJan 10, 2011 PRO-PHARMACEUTICALS RECEIVES POSITIVE FDA FEEDBACK ON DAVANAT® PHASE III CLINICAL TRIAL DESIGN TO TREAT PATIENTS WITH COLORECTAL CANCER View HTML PRO-PHARMACEUTICALS RECEIVES POSITIVE FDA FEEDBACK ON DAVANAT® PHASE III CLINICAL TRIAL DESIGN TO TREAT PATIENTS WITH COLORECTAL CANCER 17.3 KB Toggle SummaryJan 06, 2011 PRO-PHARMACEUTICALS CLOSES $2.1 MILLION OFFERING Warrant Exercises Generate Additional $1 Million View HTML PRO-PHARMACEUTICALS CLOSES $2.1 MILLION OFFERING 16.8 KB Toggle SummaryJan 04, 2011 PRO-PHARMACEUTICALS TO PRESENT CORPORATE UPDATE AT SAN FRANCISCO BIOTECH CONFERENCE View HTML PRO-PHARMACEUTICALS TO PRESENT CORPORATE UPDATE AT SAN FRANCISCO BIOTECH CONFERENCE 16.5 KB Toggle SummaryDec 21, 2010 PRO-PHARMACEUTICALS & MOUNT SINAI SCHOOL OF MEDICINE ANNOUNCE NEW LIVER FIBROSIS RESEARCH COLLABORATION View HTML PRO-PHARMACEUTICALS & MOUNT SINAI SCHOOL OF MEDICINE ANNOUNCE NEW LIVER FIBROSIS RESEARCH COLLABORATION 22.5 KB Toggle SummaryDec 07, 2010 PRO-PHARMACEUTICALS EXPANDS PATENT COVERAGE TO AUSTRALIA Patent Covers Use of DAVANAT® with Chemotherapy to Increase Effectiveness and Reduce Side Effects of Cancer Treatments View HTML PRO-PHARMACEUTICALS EXPANDS PATENT COVERAGE TO AUSTRALIA 17.4 KB Toggle SummaryNov 12, 2010 PRO-PHARMACEUTICALS REPORTS THIRD QUARTER 2010 View HTML PRO-PHARMACEUTICALS REPORTS THIRD QUARTER 2010 19.3 KB Toggle SummaryNov 02, 2010 PRO-PHARMACEUTICALS TO RECEIVE $489,000 IN FEDERAL GRANTS FOR ITS GALECTIN-TARGETING CANCER AND LIVER FIBROSIS COMPOUNDS View HTML PRO-PHARMACEUTICALS TO RECEIVE $489,000 IN FEDERAL GRANTS FOR ITS GALECTIN-TARGETING CANCER AND LIVER FIBROSIS COMPOUNDS 18.7 KB Pagination First page First Previous page Previous … Page 34 Current page 35 Page 36 Page 37 … Next page Next Last page Last
PRO-PHARMACEUTICALS NAMES PETER G. TRABER, M.D., FORMER GLAXOSMITHKLINE CHIEF MEDICAL OFFICER & PRESIDENT EMERITUS OF BAYLOR COLLEGE OF MEDICINE, PRESIDENT & CHIEF EXECUTIVE OFFICER 19 KB
PRO-PHARMACEUTICALS RECEIVES POSITIVE FDA FEEDBACK ON DAVANAT® PHASE III CLINICAL TRIAL DESIGN TO TREAT PATIENTS WITH COLORECTAL CANCER 17.3 KB
PRO-PHARMACEUTICALS & MOUNT SINAI SCHOOL OF MEDICINE ANNOUNCE NEW LIVER FIBROSIS RESEARCH COLLABORATION 22.5 KB
PRO-PHARMACEUTICALS TO RECEIVE $489,000 IN FEDERAL GRANTS FOR ITS GALECTIN-TARGETING CANCER AND LIVER FIBROSIS COMPOUNDS 18.7 KB
